Skip to results
Modify your search
NARROW
1-20 of 32
Authors: Marc S Sabatine
Journal Article
ApoB-containing lipoproteins: count, type, size, and risk of coronary artery disease
European Heart Journal, ehaf207, https://doi.org/10.1093/eurheartj/ehaf207
Published: 28 April 2025
Journal Article
Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease
European Heart Journal, Volume 46, Issue 14, 7 April 2025, Pages 1321–1331, https://doi.org/10.1093/eurheartj/ehae780
Published: 21 November 2024
Journal Article
Olpasiran lowering of lipoprotein(a) according to baseline levels: insights from the OCEAN(a)-DOSE study Get access
European Heart Journal, Volume 46, Issue 12, 21 March 2025, Pages 1162–1164, https://doi.org/10.1093/eurheartj/ehae781
Published: 20 November 2024
Journal Article
Stroke in patients with heart failure and reduced or preserved ejection fraction
European Heart Journal, Volume 44, Issue 31, 14 August 2023, Pages 2998–3013, https://doi.org/10.1093/eurheartj/ehad338
Published: 26 June 2023
Journal Article
Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2170–2183, https://doi.org/10.1093/eurheartj/ehad276
Published: 23 May 2023
Journal Article
Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54
European Heart Journal, Volume 43, Issue 48, 21 December 2022, Pages 5037–5044, https://doi.org/10.1093/eurheartj/ehac402
Published: 11 November 2022
Journal Article
Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis
European Heart Journal, Volume 44, Issue 4, 21 January 2023, Pages 293–300, https://doi.org/10.1093/eurheartj/ehac577
Published: 28 October 2022
Journal Article
Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation
European Heart Journal, Volume 43, Issue 42, 7 November 2022, Pages 4469–4479, https://doi.org/10.1093/eurheartj/ehac487
Published: 26 August 2022
Journal Article
EDITOR'S CHOICE
A polygenic risk score predicts atrial fibrillation in cardiovascular disease
European Heart Journal, Volume 44, Issue 3, 14 January 2023, Pages 221–231, https://doi.org/10.1093/eurheartj/ehac460
Published: 18 August 2022
Journal Article
Effect of evolocumab on acute arterial events across all vascular territories : results from the FOURIER trial
European Heart Journal, Volume 42, Issue 47, 14 December 2021, Pages 4821–4829, https://doi.org/10.1093/eurheartj/ehab604
Published: 19 September 2021
Journal Article
EDITOR'S CHOICE
Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF
European Heart Journal, Volume 42, Issue 36, 21 September 2021, Pages 3727–3738, https://doi.org/10.1093/eurheartj/ehab560
Published: 27 August 2021
Journal Article
EDITOR'S CHOICE
Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE–TIMI 58 trial
European Heart Journal, Volume 43, Issue 31, 14 August 2022, Pages 2958–2967, https://doi.org/10.1093/eurheartj/ehab530
Published: 24 August 2021
Journal Article
Aspirin or P2Y12 inhibition: establishing the cornerstone of antiplatelet therapy after stenting
European Heart Journal, Volume 42, Issue 4, 21 January 2021, Pages 320–322, https://doi.org/10.1093/eurheartj/ehaa741
Published: 07 December 2020
Journal Article
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)
European Heart Journal, Volume 41, Issue 36, 21 September 2020, Pages 3402–3418, https://doi.org/10.1093/eurheartj/ehaa496
Published: 21 August 2020
Journal Article
EDITOR'S CHOICE
Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
European Heart Journal, Volume 41, Issue 25, 1 July 2020, Pages 2379–2392, https://doi.org/10.1093/eurheartj/ehaa183
Published: 28 March 2020
Journal Article
EDITOR'S CHOICE
Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54 Get access
European Heart Journal, Volume 41, Issue 17, 1 May 2020, Pages 1625–1632, https://doi.org/10.1093/eurheartj/ehz821
Published: 07 December 2019
Journal Article
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
European Heart Journal, Volume 41, Issue 1, 1 January 2020, Pages 111–188, https://doi.org/10.1093/eurheartj/ehz455
Published: 31 August 2019
Journal Article
PCSK9 inhibitors: what we know, what we should have understood, and what is to come Get access
European Heart Journal, Volume 43, Issue 7, 14 February 2022, Pages e29–e31, https://doi.org/10.1093/eurheartj/ehz514
Published: 23 July 2019
Journal Article
EDITOR'S CHOICE
Persistent arterial wall inflammation in patients with elevated lipoprotein(a) despite strong low-density lipoprotein cholesterol reduction by proprotein convertase subtilisin/kexin type 9 antibody treatment
European Heart Journal, Volume 40, Issue 33, 1 September 2019, Pages 2775–2781, https://doi.org/10.1093/eurheartj/ehy862
Published: 18 December 2018
Journal Article
Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials
European Heart Journal, Volume 39, Issue 42, 07 November 2018, Pages 3810–3820, https://doi.org/10.1093/eurheartj/ehy556
Published: 20 September 2018
